Ascelia Pharma Financials
| ACE Stock | SEK 2.86 0.08 2.88% |
Ascelia |
Understanding current and past Ascelia Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ascelia Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Ascelia Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Ascelia Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Ascelia Pharma AB. Check Ascelia Pharma's Beneish M Score to see the likelihood of Ascelia Pharma's management manipulating its earnings.
Ascelia Pharma Stock Summary
Ascelia Pharma competes with Hansa Biopharma, Cantargia, Saniona AB, and BioArctic. Ascelia Pharma AB operates as an oncology focused specialty pharmaceutical company that develops medicines to enhance the life expectancy for people living with cancer and cancer-related diseases in Sweden and Denmark. The company was founded in 2000 and is headquartered in Malm, Sweden. Ascelia Pharma operates under Biotechnology classification in Sweden and is traded on Stockholm Stock Exchange. It employs 4 people.| Foreign Associate | South Africa |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0010573113 |
| Business Address | Hyllie Boulevard 34, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.ascelia.com |
| Phone | 46 735 179 118 |
| Currency | SEK - Swedish Kronor |
You should never invest in Ascelia Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ascelia Stock, because this is throwing your money away. Analyzing the key information contained in Ascelia Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ascelia Pharma Key Financial Ratios
Ascelia Pharma's financial ratios allow both analysts and investors to convert raw data from Ascelia Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Ascelia Pharma over time and compare it to other companies across industries.Ascelia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ascelia Pharma's current stock value. Our valuation model uses many indicators to compare Ascelia Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ascelia Pharma competition to find correlations between indicators driving Ascelia Pharma's intrinsic value. More Info.Ascelia Pharma AB is number one stock in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ascelia Pharma's earnings, one of the primary drivers of an investment's value.Ascelia Pharma AB Systematic Risk
Ascelia Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ascelia Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-five with a total number of output elements of sixteen. The Beta measures systematic risk based on how returns on Ascelia Pharma AB correlated with the market. If Beta is less than 0 Ascelia Pharma generally moves in the opposite direction as compared to the market. If Ascelia Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ascelia Pharma AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ascelia Pharma is generally in the same direction as the market. If Beta > 1 Ascelia Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Ascelia Pharma January 31, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ascelia Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ascelia Pharma AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ascelia Pharma AB based on widely used predictive technical indicators. In general, we focus on analyzing Ascelia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ascelia Pharma's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.78 | |||
| Information Ratio | 0.0981 | |||
| Maximum Drawdown | 21.14 | |||
| Value At Risk | (3.90) | |||
| Potential Upside | 10.33 |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.